All Articles

Review Article 
Overcoming the blood-brain barrier in primary central nervous system lymphoma: a review on new strategies to solve an old problem
Teresa Calimeri, Fabrizio Marcucci, Angelo Corti
Annals of Lymphoma
  2021;
5:
20  
Review Article 
Narrative review: biomarkers, a hope towards early diagnosis in primary CNS lymphoma
Sara Steffanoni, Teresa Calimeri
Annals of Lymphoma
  2021;
5:
19  
Review Article 
Genetic heterogeneity in follicular lymphoma
Megan Perrett, Jessica Okosun
Annals of Lymphoma
  2021;
5:
18  
Review Article 
Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrence
Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Annals of Lymphoma
  2021;
5:
17  
Review Article 
Primary central nervous system lymphoma: epidemiology and clinical presentation
Kun-Wei Song, Samar Issa, Tracy Batchelor
Annals of Lymphoma
  2021;
5:
16  
Review Article 
Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
Simone Krebs, Julia G. Barasch, Robert J. Young, Christian Grommes, Heiko Schöder
Annals of Lymphoma
  2021;
5:
15  
Review Article 
Management of relapsed follicular lymphoma
Thomas D. Rodgers, Paul M. Barr
Annals of Lymphoma
  2021;
5:
14  
Review Article 
Molecular insights into the pathogenesis of follicular lymphoma
Ting Zhou, Stefania Pittaluga, Elaine S. Jaffe
Annals of Lymphoma
  2021;
5:
12  
Review Article 
Predicting early progression in follicular lymphoma
Qin Liu, Anjali Silva, Robert Kridel
Annals of Lymphoma
  2021;
5:
11  
Review Article 
Frontline management for follicular lymphoma patients: a narrative review
Stefano Luminari, Vittoria Tarantino
Annals of Lymphoma
  2021;
5:
10  
Review Article 
Novel immunotherapy in follicular lymphoma: a narrative review
Arushi Khurana, Stephen M. Ansell
Annals of Lymphoma
  2021;
5:
9  
Review Article 
Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies
Lauren R. Schaff, Prakash Ambady, Nancy D. Doolittle, Christian Grommes
Annals of Lymphoma
  2021;
5:
8  
Review Article 
Narrative review of chronic active EBV infection—advances in clinical management
Akihisa Sawada, Masami Inoue
Annals of Lymphoma
  2021;
5:
7  
Review Article 
Biology of splenic and nodal marginal zone lymphomas
Valeria Spina, Afua A. Mensah, Alberto J. Arribas
Annals of Lymphoma
  2021;
5:
6  
Review Article 
Narrative review: secondary central nervous system lymphoma
Sara Steffanoni, Jeanette Karin Doorduijin
Annals of Lymphoma
  2021;
5:
5  
Review Article 
Antibiotic treatment for bacteria-associated extranodal marginal zone lymphoma
Marianna Sassone, Maurilio Ponzoni, Andrés J. M. Ferreri
Annals of Lymphoma
  2021;
5:
4  
Review Article 
Novel targeted agents for follicular lymphoma
Connie Lee Batlevi, Franck Morschhauser
Annals of Lymphoma
  2021;
5:
3  
Review Article 
Treatment of elderly patients with primary CNS lymphoma
Nicolas Martinez-Calle, Lisa K. Isbell, Kate Cwynarski, Elisabeth Schorb
Annals of Lymphoma
  2021;
5:
2  
Review Article 
Epidemiology of marginal zone lymphoma
James R. Cerhan, Thomas M. Habermann
Annals of Lymphoma
  2021;
5:
1  
Review Article 
The complex pathology and differential diagnosis of splenic and nodal marginal zone lymphoma
Manuela Mollejo, Miguel A. Piris
Annals of Lymphoma
  2020;
4:
18  
Review Article 
Primary vitreoretinal lymphoma: recent advances and literature review
Chiara Giuffrè, Matteo Menean, Giulio M. Modorati, Alessandro Marchese, Maria Vittoria Cicinelli, Francesco Bandello, Elisabetta Miserocchi
Annals of Lymphoma
  2020;
4:
17  
Review Article 
Radiation therapy of extranodal marginal zone lymphomas
Letizia Deantonio, Chelsea C. Pinnix, Richard Tsang
Annals of Lymphoma
  2020;
4:
16  
Review Article 
Pathology of extranodal marginal zone lymphoma at different anatomic sites
Andrew Wotherspoon
Annals of Lymphoma
  2020;
4:
15  
Review Article 
Primary central nervous system lymphoma: consolidation strategies
Carole Soussain, Andrés J. M. Ferreri
Annals of Lymphoma
  2020;
4:
14